Studies on nStudies on neutralizing anti-heparin-binding epidermal growth factor-like growth factor (HB-EGF) antibodies for drug development of cancer treatment

Shuji Sato(Takeda (United States))
Institutional Repositories DataBase (IRDB)
January 1, 2000
Cited by 0


Related Papers